ULS vs. NEO, APDN, EFX, RKT, APP, GPN, VLTO, KSPI, BR, and SYM
Should you be buying UL Solutions stock or one of its competitors? The main competitors of UL Solutions include NeoGenomics (NEO), Applied DNA Sciences (APDN), Equifax (EFX), Rocket Companies (RKT), AppLovin (APP), Global Payments (GPN), Veralto (VLTO), Joint Stock Company Kaspi.kz (KSPI), Broadridge Financial Solutions (BR), and Symbotic (SYM).
NeoGenomics (NASDAQ:NEO) and UL Solutions (NYSE:ULS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.
UL Solutions has a net margin of 0.00% compared to UL Solutions' net margin of -13.79%. NeoGenomics' return on equity of 0.00% beat UL Solutions' return on equity.
98.5% of NeoGenomics shares are held by institutional investors. 1.3% of NeoGenomics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
NeoGenomics received 483 more outperform votes than UL Solutions when rated by MarketBeat users. However, 86.67% of users gave UL Solutions an outperform vote while only 70.66% of users gave NeoGenomics an outperform vote.
UL Solutions has lower revenue, but higher earnings than NeoGenomics.
In the previous week, UL Solutions had 6 more articles in the media than NeoGenomics. MarketBeat recorded 8 mentions for UL Solutions and 2 mentions for NeoGenomics. UL Solutions' average media sentiment score of 1.35 beat NeoGenomics' score of 0.90 indicating that NeoGenomics is being referred to more favorably in the media.
NeoGenomics presently has a consensus price target of $19.78, indicating a potential upside of 52.02%. UL Solutions has a consensus price target of $40.80, indicating a potential upside of 4.97%. Given UL Solutions' higher probable upside, equities research analysts plainly believe NeoGenomics is more favorable than UL Solutions.
Summary
UL Solutions beats NeoGenomics on 7 of the 13 factors compared between the two stocks.
Get UL Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for ULS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ULS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
UL Solutions Competitors List
Related Companies and Tools
